Literature DB >> 31735330

Heparin improves alveolarization and vascular development in hyperoxia-induced bronchopulmonary dysplasia by inhibiting neutrophil extracellular traps.

Yuanyuan Sun1, Cuie Chen2, Xixi Zhang3, Shi Wang4, Ronghe Zhu1, Aihua Zhou1, Shujun Chen2, Jianhua Feng5.   

Abstract

The objective of this study was to assess the role of NETs in BPD of hyperoxia-induced rat model and the effect of heparin on alveolarization and vascular development in BPD. The neonatal rats exposed to 90% oxygen continuously for 7 days to mimic BPD, meanwhile, the rats were injected by different doses of histones to evaluate the impact on lung injury. The newborn rats exposed to hyperoxia were injected by different doses of heparin (250 U/kg, 500 U/kg) or anti-H4 antibody to evaluate the effect of heparin. Histones and hyperoxia impaired alveolarization with the increase of mean linear intercept (MLI) and the decrease of radial alveolar count (RAC), decreased lung angiogenesis with the decrease expression of VEGF, and increased the expression of NETs, histones and pro-inflammatory factor. However, low dose heparin (250U/kg) administration enhanced survival, improved alveolarization and vascular development in hyperoxia-induced BPD, as well as reduced expression of NETs, histones and pro-inflammatory factor. We concluded that heparin improves alveolarization and vascularization in BPD by inhibiting NETs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Heparin; Histones; Hyperoxia; Neutrophil extracellular traps

Year:  2019        PMID: 31735330     DOI: 10.1016/j.bbrc.2019.11.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand.

Authors:  Esmeiry Ventura-Santana; Joshua R Ninan; Caitlin M Snyder; Emeka B Okeke
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 2.  Endothelial Dysfunction Induced by Extracellular Neutrophil Traps Plays Important Role in the Occurrence and Treatment of Extracellular Neutrophil Traps-Related Disease.

Authors:  Shuyang Yu; Jingyu Liu; Nianlong Yan
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 3.  Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem.

Authors:  Raquel Arroyo; Paul S Kingma
Journal:  Respir Res       Date:  2021-05-08

4.  Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps.

Authors:  Cuie Chen; Huachun Weng; Xixi Zhang; Shi Wang; Chaosheng Lu; Hongxing Jin; Shujun Chen; Yuanyuan Liu; Anqun Sheng; Yuanyuan Sun
Journal:  Front Pediatr       Date:  2020-07-03       Impact factor: 3.418

Review 5.  Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis.

Authors:  Zhaoyuan Chen; Hao Zhang; Mengdi Qu; Ke Nan; Hanzhong Cao; Juan P Cata; Wankun Chen; Changhong Miao
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

6.  Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

Authors:  Paulo Roberto Slud Brofman; Alejandro Correa; Carmen Lúcia Kuniyoshi Rebelatto; Alexandra Cristina Senegaglia; Claudio Luciano Franck; Debora Regina Daga; Patrícia Shigunov; Marco Augusto Stimamiglio; Daniela Boscaro Marsaro; Bruna Schaidt; Andressa Micosky; Ana Paula de Azambuja; Cleverson Alex Leitão; Ricardo Rasmussen Petterle; Valderez Ravaglio Jamur; Isadora May Vaz; Antônio Paulo Mallmann; Hipólito Carraro Junior; Eduardo Ditzel
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

Review 7.  When inflammation meets lung development-an update on the pathogenesis of bronchopulmonary dysplasia.

Authors:  Lena Holzfurtner; Tayyab Shahzad; Ying Dong; Lisa Rekers; Ariane Selting; Birte Staude; Tina Lauer; Annesuse Schmidt; Stefano Rivetti; Klaus-Peter Zimmer; Judith Behnke; Saverio Bellusci; Harald Ehrhardt
Journal:  Mol Cell Pediatr       Date:  2022-04-20

Review 8.  Venous Thromboembolism in Sepsis: From Bench to Bedside.

Authors:  Eleonora Galli; Elena Maggio; Fulvio Pomero
Journal:  Biomedicines       Date:  2022-07-08

Review 9.  Patients with COVID-19: in the dark-NETs of neutrophils.

Authors:  Maximilian Ackermann; Hans-Joachim Anders; Rostyslav Bilyy; Gary L Bowlin; Christoph Daniel; Rebecca De Lorenzo; Mikala Egeblad; Timo Henneck; Andrés Hidalgo; Markus Hoffmann; Bettina Hohberger; Yogendra Kanthi; Mariana J Kaplan; Jason S Knight; Jasmin Knopf; Elzbieta Kolaczkowska; Paul Kubes; Moritz Leppkes; Aparna Mahajan; Angelo A Manfredi; Christian Maueröder; Norma Maugeri; Ioannis Mitroulis; Luis E Muñoz; Teluguakula Narasaraju; Elisabeth Naschberger; Indira Neeli; Lai Guan Ng; Marko Z Radic; Konstantinos Ritis; Patrizia Rovere-Querini; Mirco Schapher; Christine Schauer; Hans-Uwe Simon; Jeeshan Singh; Panagiotis Skendros; Konstantin Stark; Michael Stürzl; Johan van der Vlag; Peter Vandenabeele; Ljubomir Vitkov; Maren von Köckritz-Blickwede; Cansu Yanginlar; Shida Yousefi; Alexander Zarbock; Georg Schett; Martin Herrmann
Journal:  Cell Death Differ       Date:  2021-05-24       Impact factor: 15.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.